Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office	ID
Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers	565
Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers	2507
Hodges, Nick, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers	2276
Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers	2301
Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers	585
Mazurchuk, Richard, Ph.D. richard.mazurchuk@nih.gov 240-276-7126	5E582	Program Officer \| Cancer Biomarkers	587
Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers	597
Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Program Officer \| Cancer Biomarkers	603
Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers	653
Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers	629
Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers	639
Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers	644

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Grimm, Lars J	Duke University United States	Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications	5R01CA271237-03	Richard Mazurchuk, Ph.D.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer	5U01CA152662-13	Guillermo Marquez, Ph.D.
Hanash, Samir M	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Lung Cancer Early Detection	5U01CA271888-03	Guillermo Marquez, Ph.D.
Hecht, Stephen S	University Of Minnesota United States	High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck	5R01CA263084-04	Wendy Wang, Ph.D., M.Sc.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-07	Richard Mazurchuk, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-03	Wendy Wang, Ph.D., M.Sc.
Hirsch, Fred R	Icahn School Of Medicine At Mount Sinai United States	Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses	3U54CA260560-02S3	Guillermo Marquez, Ph.D.
Hitchins, Megan P	Cedars-Sinai Medical Center United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	5R01CA252042-04	Matthew Young, Ph.D.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-08	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	5U01CA288375-02	Matthew Young, Ph.D.
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06	Guillermo Marquez, Ph.D.
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	1R01CA283687-01A1	Guillermo Marquez, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-03	Matthew Young, Ph.D.
Hur, Chin	Columbia University Health Sciences United States	Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype	3R01CA257333-04S1	Matthew Young, Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-04	Matthew Young, Ph.D.